Division of Vascular Surgery, Northwestern University, Chicago, Ill 60611, USA.
J Vasc Surg. 2010 Jan;51(1):230-41. doi: 10.1016/j.jvs.2009.08.073.
Critical limb ischemia (CLI) continues to be a significantly morbid disease process for the aging population. Rigid guidelines for the management of patients with CLI are inappropriate due to the complexities that are involved in optimally treating these patients. A thin line exists in the decision process between medical management vs surgical management by revascularization or amputation, and the perception of "success" in this patient population is evolving. This review explores these issues and examines the challenges the treating physician will face when managing the care of patients with CLI. The epidemiology and natural history of CLI is discussed, along with the pathophysiology of the disease process. A review of the literature in regards to the different treatment modalities is presented to help the physician optimize therapy for patients with CLI. New scoring systems to help predict outcomes in patients with CLI undergoing revascularization or amputation are discussed, and an overview of the current status of patient-oriented outcomes is provided. Finally, we briefly examine emerging therapies for the treatment of CLI and provide an algorithm to help guide the practicing physician on how to approach the critically ischemic limb with regard to the complicated issues surrounding these patients.
严重肢体缺血(CLI)仍然是老年人群中一种严重的疾病。由于在为这些患者提供最佳治疗方面存在复杂性,严格的 CLI 患者管理指南并不适用。在血管重建或截肢的医学治疗与手术治疗之间的决策过程中存在一条微妙的界限,而在这类患者人群中,“成功”的观念正在不断演变。本文探讨了这些问题,并研究了治疗医生在管理 CLI 患者护理时将面临的挑战。本文讨论了 CLI 的流行病学和自然病史,以及疾病过程的病理生理学。本文还回顾了有关不同治疗方式的文献,以帮助医生为 CLI 患者优化治疗。讨论了新的评分系统,以帮助预测接受血管重建或截肢的 CLI 患者的预后,并提供了当前患者导向结局的概述。最后,我们简要探讨了 CLI 的新兴治疗方法,并提供了一个算法,以帮助指导临床医生如何处理严重肢体缺血的问题,因为这些患者的问题非常复杂。